{"id":"W4317862685","doi":"10.1200/jco.2023.41.4_suppl.lba294","title":"INTEGRATE IIa: A randomised, double-blind, phase III study of regorafenib versus placebo in refractory advanced gastro-oesophageal cancer (AGOC)—A study led by the Australasian Gastro-intestinal Trials Group (AGITG).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; McGill University Health Centre","funders":"","keywords":"Medicine; Regorafenib; Internal medicine; Hazard ratio; Placebo; Population; Progression-free survival; Clinical endpoint; Cancer; Oncology; Clinical trial; Gastroenterology; Confidence interval; Colorectal cancer; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003757662,0.003107241,0.00474447,0.0007109742,0.0005862011,0.001481688,0.001600204,0.002969314,0.01018915],"category_scores_gemma":[0.002583459,0.001257968,0.003561049,0.0007041164,0.001616119,0.001340619,0.0007137552,0.003903079,0.001824424],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009529215,"about_ca_system_score_gemma":0.00182501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001172187,"about_ca_topic_score_gemma":0.002689159,"domain_scores_codex":[0.9989854,0.0005625761,0.00006503608,0.0001834837,0.00007041579,0.0001332283],"domain_scores_gemma":[0.9987029,0.0003275982,0.0003609513,0.0001201512,0.00009154181,0.0003968583],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9857305,0.00501433,0.0001650322,0.0006161035,0.0006986479,0.00001847895,0.00003161271,0.0001953927,0.002004657,0.0000660624,0.0005684888,0.004890682],"study_design_scores_gemma":[0.9668341,0.03203825,0.0003452011,0.00001906721,0.0002314972,0.000009796211,0.000007564138,0.00009029613,0.000107529,0.00005207666,0.000257115,0.000007410275],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9450747,0.01492515,0.001973272,0.001502585,0.002160511,0.0240031,0.004569603,0.0005015437,0.005289536],"genre_scores_gemma":[0.9455473,0.007362383,0.004229249,0.00330334,0.001609014,0.02643928,0.003373063,0.00009834169,0.008038039],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01018915,"threshold_uncertainty_score":0.03408611,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2226914900011004,"score_gpt":0.5219122760889366,"score_spread":0.2992207860878362,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}